Remarkably, 69.66% of the reverse genes were enriched in immune effect-related KEGG pathways, including the JAK-STAT signaling pathway, PD-L1 expression, and PD-1 checkpoint pathway in cancer, Th1 and Th2 (Figure 4D). The gene discussed is CD274; the disease is cancer.